Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome

Avishai A. Alkalay, Tingwei Guo, Cristina Montagna, M. Cristina Digilio, Bruno Dallapiccola, Bruno Marino, Bernice E. Morrow

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cytogenetic studies of a male child carrying the 22q11.2 deletion common in patients with velo-cardio-facial/DiGeorge syndrome showed an unexpected rearrangement of the 22q11.2 region in his normal appearing mother. The mother carried a 3Mb deletion on one copy and a reciprocal, similar sized duplication on the other copy of chromosome 22q11.2 as shown by fluorescence in situ hybridization and array comparative genome hybridization analyses. The most parsimonious mechanism for the rearrangement is a mitotic non-allelic homologous recombination event in a cell in the early embryo soon after fertilization. The normal phenotype of the mother can be explained by the theory of genetic dosage compensation. This is the second documented case of such an event for this or any genomic disorder. This finding helps to reinforce this phenomenon in a human model, and has significant implications for recurrence risks for the dose-compensated mother.

Original languageEnglish (US)
Pages (from-to)548-554
Number of pages7
JournalAmerican Journal of Medical Genetics, Part A
Volume155
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

DiGeorge Syndrome
Mothers
Comparative Genomic Hybridization
Homologous Recombination
Fluorescence In Situ Hybridization
Fertilization
Cytogenetics
Embryonic Structures
Chromosomes
Phenotype
Recurrence

Keywords

  • Cytogenetic analysis
  • DiGeorge syndrome
  • Dosage compensation
  • Fluorescence
  • Genetic
  • In situ hybridization
  • Oligonucleotide array
  • Recurrence risks
  • Sequence analysis

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome. / Alkalay, Avishai A.; Guo, Tingwei; Montagna, Cristina; Digilio, M. Cristina; Dallapiccola, Bruno; Marino, Bruno; Morrow, Bernice E.

In: American Journal of Medical Genetics, Part A, Vol. 155, No. 3, 03.2011, p. 548-554.

Research output: Contribution to journalArticle

Alkalay, Avishai A. ; Guo, Tingwei ; Montagna, Cristina ; Digilio, M. Cristina ; Dallapiccola, Bruno ; Marino, Bruno ; Morrow, Bernice E. / Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome. In: American Journal of Medical Genetics, Part A. 2011 ; Vol. 155, No. 3. pp. 548-554.
@article{7210cd0585314523be681dd74aa71424,
title = "Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome",
abstract = "Cytogenetic studies of a male child carrying the 22q11.2 deletion common in patients with velo-cardio-facial/DiGeorge syndrome showed an unexpected rearrangement of the 22q11.2 region in his normal appearing mother. The mother carried a 3Mb deletion on one copy and a reciprocal, similar sized duplication on the other copy of chromosome 22q11.2 as shown by fluorescence in situ hybridization and array comparative genome hybridization analyses. The most parsimonious mechanism for the rearrangement is a mitotic non-allelic homologous recombination event in a cell in the early embryo soon after fertilization. The normal phenotype of the mother can be explained by the theory of genetic dosage compensation. This is the second documented case of such an event for this or any genomic disorder. This finding helps to reinforce this phenomenon in a human model, and has significant implications for recurrence risks for the dose-compensated mother.",
keywords = "Cytogenetic analysis, DiGeorge syndrome, Dosage compensation, Fluorescence, Genetic, In situ hybridization, Oligonucleotide array, Recurrence risks, Sequence analysis",
author = "Alkalay, {Avishai A.} and Tingwei Guo and Cristina Montagna and Digilio, {M. Cristina} and Bruno Dallapiccola and Bruno Marino and Morrow, {Bernice E.}",
year = "2011",
month = "3",
doi = "10.1002/ajmg.a.33861",
language = "English (US)",
volume = "155",
pages = "548--554",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Genetic dosage compensation in a family with velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome

AU - Alkalay, Avishai A.

AU - Guo, Tingwei

AU - Montagna, Cristina

AU - Digilio, M. Cristina

AU - Dallapiccola, Bruno

AU - Marino, Bruno

AU - Morrow, Bernice E.

PY - 2011/3

Y1 - 2011/3

N2 - Cytogenetic studies of a male child carrying the 22q11.2 deletion common in patients with velo-cardio-facial/DiGeorge syndrome showed an unexpected rearrangement of the 22q11.2 region in his normal appearing mother. The mother carried a 3Mb deletion on one copy and a reciprocal, similar sized duplication on the other copy of chromosome 22q11.2 as shown by fluorescence in situ hybridization and array comparative genome hybridization analyses. The most parsimonious mechanism for the rearrangement is a mitotic non-allelic homologous recombination event in a cell in the early embryo soon after fertilization. The normal phenotype of the mother can be explained by the theory of genetic dosage compensation. This is the second documented case of such an event for this or any genomic disorder. This finding helps to reinforce this phenomenon in a human model, and has significant implications for recurrence risks for the dose-compensated mother.

AB - Cytogenetic studies of a male child carrying the 22q11.2 deletion common in patients with velo-cardio-facial/DiGeorge syndrome showed an unexpected rearrangement of the 22q11.2 region in his normal appearing mother. The mother carried a 3Mb deletion on one copy and a reciprocal, similar sized duplication on the other copy of chromosome 22q11.2 as shown by fluorescence in situ hybridization and array comparative genome hybridization analyses. The most parsimonious mechanism for the rearrangement is a mitotic non-allelic homologous recombination event in a cell in the early embryo soon after fertilization. The normal phenotype of the mother can be explained by the theory of genetic dosage compensation. This is the second documented case of such an event for this or any genomic disorder. This finding helps to reinforce this phenomenon in a human model, and has significant implications for recurrence risks for the dose-compensated mother.

KW - Cytogenetic analysis

KW - DiGeorge syndrome

KW - Dosage compensation

KW - Fluorescence

KW - Genetic

KW - In situ hybridization

KW - Oligonucleotide array

KW - Recurrence risks

KW - Sequence analysis

UR - http://www.scopus.com/inward/record.url?scp=79951963982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951963982&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33861

DO - 10.1002/ajmg.a.33861

M3 - Article

C2 - 21337693

AN - SCOPUS:79951963982

VL - 155

SP - 548

EP - 554

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -